1834 Investment Advisors Co. Acquires 71,884 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• In the fourth quarter 1834 Investment Advisors increased its stake in Healthpeak Properties (NYSE: DOC) by 327%, purchasing 71,884 shares to own 93,870 shares valued at about $1.51 million.
• Institutional ownership stands at 93.57%, with major moves including JPMorgan Chase boosting its position by 41% (+8.21 million shares to 28.24 million) and Mitsubishi UFJ adding 126,322 shares.
• Healthpeak declared a monthly dividend of $0.1017 (annualized yield ~7.4%), with an ex-dividend date of June 15 and payment scheduled for June 26.

1834 Investment Advisors Co. boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 327.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 93,870 shares of the real estate investment trust's stock after purchasing an additional 71,884 shares during the period. 1834 Investment Advisors Co.'s holdings in Healthpeak Properties were worth $1,509,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Vanderbilt University purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,263,000. Argent Advisors Inc. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $1,536,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Healthpeak Properties by 7.0% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust's stock valued at $37,063,000 after purchasing an additional 126,322 shares during the last quarter. Twin City Private Wealth LLC bought a new position in Healthpeak Properties during the third quarter valued at $1,148,000. Finally, JPMorgan Chase & Co. grew its holdings in Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the period. Institutional investors own 93.57% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Citigroup lowered their target price on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research note on Wednesday, April 1st. Wall Street Zen raised Healthpeak Properties from a "sell" rating to a "hold" rating in a report on Saturday, April 11th. UBS Group initiated coverage on Healthpeak Properties in a research note on Monday, April 20th. They issued a "neutral" rating and a $17.00 price objective on the stock. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They set a "neutral" rating and a $17.00 price objective on the stock. Finally, Weiss Ratings upgraded shares of Healthpeak Properties from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Monday, January 26th. Six equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $19.04.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $16.43 on Monday. Healthpeak Properties, Inc. has a 1-year low of $15.71 and a 1-year high of $19.68. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The firm has a market capitalization of $11.42 billion, a PE ratio of 164.28, a price-to-earnings-growth ratio of 2.27 and a beta of 1.10. The firm's 50 day simple moving average is $17.01 and its 200 day simple moving average is $17.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million during the quarter, compared to the consensus estimate of $685.14 million. During the same period last year, the firm earned $0.46 EPS. The business's quarterly revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 7.4%. The ex-dividend date is Monday, June 15th. Healthpeak Properties's dividend payout ratio is currently 1,220.00%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.